Showing results (731-740 of 3,073) with videos related to
Sort By:
Pageof 308
Pharmacological Reports : PR|November 15, 2022
Health-related quality of life in survivors of severe COVID-19 infectionGabriele d'Ettorre, Paolo Vassalini, Vincenzo Coppolelli, et al.Pharmacological Reports : PR|July 3, 2016
Traxoprodil augments the antidepressant-like activity of agomelatine but not of mianserin or tianeptine in the forced swim test in miceWeronika Stasiuk, Anna Serefko, Aleksandra Szopa, et al.Pharmacological Reports : PR|June 15, 2026
Italian regional data and oropharyngeal adverse events to drugs and vaccines: insights from a 3-year spontaneous reporting (2022-2024)Liberata Sportiello, Mario Gaio, Alessia Zinzi, et al.Pharmacological Reports : PR|June 15, 2026
Hypocholesterolemic agents and the gut microbiota: a review of interactions and modulatory activityManuel Mântua E Garcia, Virginie Xavier, Ricardo C Calhelha, et al.Pharmacological Reports : PR|June 24, 2023
Automated machine learning approach for developing a quantitative structure-activity relationship model for cardiac steroid inhibition of Na+/K+-ATPaseYohei Takada, Kazuhiro KanekoPharmacological Reports : PR|August 4, 2023
Changes in expression of mesothelial BBS genes in 2D and 3D after lithium chloride and ammonium sulphate induction of primary cilium disturbance: a pilot studyErasmia Rouka, Rajesh M Jagirdar, Ioannis Sarrigeorgiou, et al.Pharmacological Reports : PR|July 15, 2026
Phase-specific involvement of BDNF-TrkB signaling in HSV-1-induced herpetic pain and its transition to postherpetic neuralgia-like painIchiro Takasaki, Arata Inoue, Aoi Yoshida, et al.Pharmacological Reports : PR|September 1, 2021
FNF-12, a novel benzylidene-chromanone derivative, attenuates inflammatory response in in vitro and in vivo asthma models mediated by M2-related Th2 cytokines via MAPK and NF-kB signalingMohammad Abohassan, Mesfer Al Shahrani, Mohammad Y Alshahrani, et al.Pharmacological Reports : PR|September 1, 2015
Nanoparticles in endothelial theranosticsSzczepan Zapotoczny, Krzysztof Szczubialka, Maria NowakowskaPharmacological Reports : PR|August 12, 2026
The course of platinum-based chemotherapy is associated with the risk of hematological complications during poly(ADP-ribose) polymerase (PARP) inhibitor therapy in patients with ovarian cancerCezary Miedziarek, Aleksandra Gładych-Macioszek, Michał Potograbski, et al.Pageof 308